Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Recruiting 1Completed 1

Sponsor Class

NIH 8OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Breast 3Thoracic 2Myeloid 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Metabolic Syndrome 1Lymphoma, Non-Hodgkin 1Leukemia, Lymphocytic, Chronic, B-Cell 1Heart Failure 1Cardiovascular Diseases 1Cardiotoxicity 1Cardiomyopathies 1

Interventions

Cyclophosphamide 886Rituximab 864Vincristine 382Etoposide 381fludarabine 342Cytarabine 341Doxorubicin 340fludarabine phosphate 319Methotrexate 310Dexamethasone 283Prednisone 282Lenalidomide 245Filgrastim 228Melphalan 200Peripheral Blood Stem Cell Transplantation 184Radiotherapy 175Whole-Body Irradiation 172Busulfan 165Mycophenolic Acid 161venetoclax 158Bendamustine Hydrochloride 158Granulocyte Colony-Stimulating Factor 151Tacrolimus 145ibrutinib 144Bortezomib 138obinutuzumab 125Gemcitabine 113Cyclosporine 110Antilymphocyte Serum 103Carmustine 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Electrocardiography × Lymphoid × Clear all
NCT07041827 2025-06-27

CLARITY

The Netherlands Cancer Institute

Completed
217 enrolled
Lymphoid

Cardiovascular Diseases, Heart Failure, Lymphoma, Non-Hodgkin, Cardiomyopathies, Metabolic Syndrome, Cardiotoxicity

NCT03898596 2025-05-01

Umbilical Vessel Catheterization Under ECG Monitoring and Guidance

Stanford University

Phase NA Recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05521178 2024-10-15

Cardiotoxicities in Patients Receiving BTKi

Dana-Farber Cancer Institute

Withdrawn
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡